Arvinas, Inc. SEC filings ARVN
Arvinas, Inc. has 602 filings in SEC EDGAR's recent list, going back to Oct 23, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Nov 3, 2026 | — |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| S-8 | Employee stock plan registration | Sep 28, 2026 | — |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 144 | Notice of proposed sale | Sep 9, 2026 | — |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| S-8 | Employee stock plan registration | Aug 31, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Jul 9, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 24, 2026 |
| 144 | Notice of proposed sale | Jun 23, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 17, 2026 |
| 144 | Notice of proposed sale | Jun 17, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 12, 2026 | May 11, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 1, 2026 | May 1, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 19, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 18, 2026 | Mar 18, 2026 |
| 144 | Notice of proposed sale | Mar 17, 2026 | — |
| 4/A | Form 4/a | Mar 12, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 3 | Initial insider ownership | Feb 18, 2026 | Feb 12, 2026 |
| 144 | Notice of proposed sale | Feb 13, 2026 | — |
| 144 | Notice of proposed sale | Feb 13, 2026 | — |
| 144 | Notice of proposed sale | Feb 13, 2026 | — |
| 144 | Notice of proposed sale | Feb 13, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 20, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2025 | Oct 5, 2025 |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Sep 17, 2025 | Sep 17, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 22, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 30, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 24, 2025 |
| 144 | Notice of proposed sale | Jun 23, 2025 | — |
| 4 | Insider transaction | Jun 18, 2025 | Jun 17, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jun 16, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Other events
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | May 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
May 1, 2025 | Apr 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 4, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 18, 2025 |
| 144 | Notice of proposed sale | Mar 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 11, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 24, 2025 |
| 144 | Notice of proposed sale | Feb 24, 2025 | — |
| 144 | Notice of proposed sale | Feb 24, 2025 | — |
| 144 | Notice of proposed sale | Feb 24, 2025 | — |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| S-8 | Employee stock plan registration | Feb 11, 2025 | — |
| 10-K | Annual report | Feb 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Jan 22, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 16, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 12, 2024 | Nov 8, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 22, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 11, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Sep 10, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 20, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Jul 30, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2024 | Jul 30, 2024 |
| S-8 | Employee stock plan registration | Jun 27, 2024 | — |
| 4 | Insider transaction | Jun 26, 2024 | Jun 24, 2024 |
| 3 | Initial insider ownership | Jun 26, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2024 | Jun 22, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 17, 2024 |
| 3 | Initial insider ownership | Jun 18, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 17, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2024 | May 29, 2024 |
| 8-K |
Current report
Other events
|
May 30, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 144 | Notice of proposed sale | May 20, 2024 | — |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 16, 2024 | May 16, 2024 |
| 144 | Notice of proposed sale | May 15, 2024 | — |
| 144 | Notice of proposed sale | May 13, 2024 | — |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 17, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 16, 2024 | — |
| DEF 14A | Proxy statement | Apr 16, 2024 | May 29, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 11, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Mar 21, 2024 | Mar 18, 2024 |
| 3 | Initial insider ownership | Mar 21, 2024 | Mar 18, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1655759
- Former names
- ARVINAS INC. (until Oct 10, 2018); ARVINAS HOLDING COMPANY, LLC (until Sep 28, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.